| 1 |
32483952 | [A Case of Subcutaneous Scrotal Metastasis from Primary Gastric Cancer]. | 2020 May |
1 |
| 2 |
32793829 | Development of prediction models for the sensitivity of oral squamous cell carcinomas to preoperative S-1 administration. | 2020 Aug |
1 |
| 3 |
31011915 | Pharmacokinetics of S-1 monotherapy in plasma and in tears for gastric cancer patients. | 2019 Jun |
2 |
| 4 |
29445512 | Changes in tear volume and ocular symptoms of patients receiving oral anticancer drug S-1. | 2018 |
1 |
| 5 |
29931401 | Determination of 5-fluorouracil and tegafur in tear fluid of patients treated with oral fluoropyrimidine anticancer agent, S-1. | 2018 Jul |
4 |
| 6 |
30524750 | Impact of relative dose intensity on bone marrow suppression induced by S-1: retrospective observational study. | 2018 |
1 |
| 7 |
26715117 | Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer. | 2017 Jan |
1 |
| 8 |
27966431 | Adjuvant S-1 chemotherapy after curative resection of gastric cancer in Chinese patients: assessment of treatment tolerability and associated risk factors. | 2017 Feb |
1 |
| 9 |
27980246 | Meta-analysis Exploring the Effectiveness of S-1-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer. | 2017 Jan |
1 |
| 10 |
28159957 | Pharmacokinetics of initial full and subsequent reduced doses of S-1 in patients with locally advanced head and neck cancer-effect of renal insufficiency. | 2017 May 1 |
1 |
| 11 |
28449472 | Definitive concurrent chemoradiotherapy with S-1 and cisplatin in elderly esophageal squamous cell carcinoma patients. | 2017 Mar |
1 |
| 12 |
28496035 | Alleviating effects of artificial tear instillation on S-1-induced ocular toxicity in dogs. | 2017 |
1 |
| 13 |
28698442 | Incidence of Ophthalmic Disorders in Patients Treated with the Antineoplastic Agent S-1. | 2017 Jun |
1 |
| 14 |
29191594 | A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 1202. | 2017 Oct |
1 |
| 15 |
27822036 | Improvement of intratumor microdistribution of PEGylated liposome via tumor priming by metronomic S-1 dosing. | 2016 |
1 |
| 16 |
25810324 | Postgastrectomy pharmacokinetic changes of S-1 in patients with localized advanced gastric cancer. | 2015 Aug |
1 |
| 17 |
25874010 | Risk factors for discontinuation of s-1 adjuvant chemotherapy for gastric cancer. | 2015 |
1 |
| 18 |
25032886 | Efficacy of S-1 in colorectal cancer. | 2014 Aug |
1 |
| 19 |
25109221 | Efficacy of S-1 in non-small cell lung cancer. | 2014 Sep |
1 |
| 20 |
23710321 | A Case of Common Bile Duct Cancer That Completely Responded to Combination Chemotherapy of Gemcitabine and TS-1. | 2013 May |
1 |
| 21 |
23982118 | Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer. | 2013 Nov |
1 |
| 22 |
23998404 | Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer. | 2013 Nov |
1 |
| 23 |
22241359 | [Evaluation of the S-1 granule forms in gastric cancer patients who received treatment with S-1 capsule-questionnaire survey about drug dosage forms]. | 2012 Jan |
1 |
| 24 |
22251528 | Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil and oteracil potassium) for colorectal cancer. | 2012 Jan-Feb |
1 |
| 25 |
22322240 | Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy. | 2012 May |
1 |
| 26 |
22860709 | S-1 for the treatment of gastrointestinal cancer. | 2012 Sep |
1 |
| 27 |
23289150 | [Pharmacokinetics of S-1 capsule in patients with advanced gastric cancer]. | 2012 Oct |
1 |
| 28 |
20714726 | A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan. | 2011 Jun |
2 |
| 29 |
21487460 | Transient effectiveness of an oral 5-Fluorouracil derivative, s-1, for epirubicin, cyclophosphamide and Paclitaxel refractory skin metastases from possible occult breast cancer in a male. | 2011 Feb 23 |
1 |
| 30 |
21675835 | A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma. | 2011 Jun |
1 |
| 31 |
22162925 | Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies. | 2011 |
1 |
| 32 |
19921195 | Can the 2-(13)C-uracil breath test be used to predict the effect of the antitumor drug S-1? | 2010 Jul |
2 |
| 33 |
20414030 | [Successful management with S-1 of recurrent gastric cancer after adjuvant chemotherapy with paclitaxel/UFT]. | 2010 Apr |
1 |
| 34 |
20424000 | Synergistic antitumor effect of S-1 and HER2-targeting agents in gastric cancer with HER2 amplification. | 2010 May |
1 |
| 35 |
20559897 | Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancer. | 2010 Jul |
1 |
| 36 |
22966328 | Hepatic metastasis from bile duct cancer of the ampulla is effectively controlled by multidisciplinary treatment including S-1, gemcitabine and bevacizumab: A case report. | 2010 May |
1 |
| 37 |
19052037 | Development history and concept of an oral anticancer agent S-1 (TS-1): its clinical usefulness and future vistas. | 2009 Jan |
1 |
| 38 |
19243284 | S-1: a promising new oral fluoropyrimidine derivative. | 2009 Mar |
1 |
| 39 |
19632949 | S-1: a new oral fluoropyrimidine in the treatment of patients with advanced non-small-cell lung cancer. | 2009 Jul |
1 |
| 40 |
18383902 | Successful treatment with S-1 plus CPT-11 for lymph node metastasis from colon cancer: report of a case. | 2008 Jan-Feb |
2 |
| 41 |
16786333 | Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer. | 2007 Feb |
1 |
| 42 |
16549996 | Effect of gastrectomy on the pharmacokinetics of 5-fluorouracil and gimeracil after oral administration of S-1. | 2006 Apr |
1 |
| 43 |
16897985 | Rapid development of S-1 in the west for therapy of advanced gastric carcinoma. | 2006 Jun |
1 |
| 44 |
16897986 | [S-1 as a single agent for colorectal cancer]. | 2006 Jun |
1 |
| 45 |
15944764 | Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts. | 2005 Jul |
2 |
| 46 |
15075664 | The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors. | 2004 Feb |
2 |
| 47 |
15160338 | Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma. | 2004 Jun 1 |
1 |
| 48 |
15224197 | Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer. | 2004 |
1 |
| 49 |
15297391 | Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies. | 2004 Aug 1 |
1 |
| 50 |
15331922 | Safety and efficacy of S-1, a novel oral fluorouracil antitumor drug, for a chronic renal failure patient maintained on hemodialysis. | 2004 |
2 |